Genagon Theraputics Revenue and Competitors
Estimated Revenue & Valuation
- Genagon Theraputics's estimated annual revenue is currently $3M per year.
- Genagon Theraputics's estimated revenue per employee is $201,000
Employee Data
- Genagon Theraputics has 15 Employees.
- Genagon Theraputics grew their employee count by -17% last year.
Genagon Theraputics's People
| Name | Title | Email/Phone |
|---|
Genagon Theraputics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $21.3M | 106 | 25% | N/A | N/A |
#2 | $61.7M | 307 | 5% | N/A | N/A |
#3 | $15.1M | 75 | -12% | N/A | N/A |
#4 | $120.6M | 600 | 22% | N/A | N/A |
#5 | $29.7M | 148 | 21% | N/A | N/A |
#6 | $27.7M | 138 | -67% | N/A | N/A |
#7 | $31.2M | 155 | 14% | N/A | N/A |
#8 | $25.3M | 126 | 29% | N/A | N/A |
#9 | $108.7M | 541 | 26% | N/A | N/A |
#10 | $1200M | 1397 | -6% | $2.4B | N/A |
What Is Genagon Theraputics?
Genagon Therapeutics drug development is based on ground-breaking discoveries of unstudied proteins and their life cycles in innate immune cells. Genagon was founded in 2015 and is growing a strong and broad patent portfolio with opportunities for internal development and future partnerships. The company is supported financially by among others, Beijer Ventures and Almi Invest.
keywords:N/A
N/A
Total Funding
15
Number of Employees
$3M
Revenue (est)
-17%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Genagon Theraputics News
2022-03-22 - Notice of Annual General Meeting 2022 in Enzymatica AB (publ)
Guest Researcher at the Department of Immunology , Pittsburgh University, USA . Other current assignments: CEO, Genagon Therapeutics AB .
Other Companies in Stockholm
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $1.4M | 15 | 88% | N/A |
#2 | $1.3M | 15 | -42% | N/A |
#3 | $2.3M | 15 | 200% | N/A |
#4 | $3.5M | 15 | -12% | N/A |
#5 | $2.2M | 15 | 0% | N/A |